COST EFFECTIVENESS ANALYSIS OF HYPERTENSION AND DIABETES MELLITUS TREATMENT AT EFARINA ATAHAM HOSPITAL PANGKALAN KERINCI
Authors
Files
Key Information
Journal
Published in Vol. 1 No. 4 (2020) of MEDALION Journal: Medical Research, Nursing, Health and Midwife Participation.
MEDALION Journal: Medical Research, Nursing, Health and Midwife Participation
Editor-in-Chief
dr. Harianto Ludirdja, DIPL.CIB, MSc, Sp.Ok, FIHFAA
E-ISSN
2986-7754
Frequency
4 Issues/Year
Language
English
Review Policy
Double-Blind Peer Review
Platform
Open Journal Systems (OJS)
Publisher
PT. Radja Intercontinental Publishing
Journal URL
https://medalionjournal.com/index.php/go/index
MEDALION JOURNAL: Medical Research, Nursing, Health and Midwife Participation is a peer-reviewed, open access journal which publishes original research articles and review articles in all areas of nursing and midwifery, research and education. The aim of the journal is to contribute to the growing field of nursing practice and provide a platform for researchers, physicians and healthcare professionals. Topics of interest include: Nursing education Community nursing Specialist nursing topics Policies in nursing and healthcare Ethical issues Healthcare systems Healthcare management Pediatrics nursing
About the JournalAbstract
Hypertension is a condition in which blood pressure increases above (≥140/90 mmHg). The prevalence in Indonesia is 32.2% and only 24.2% of these hypertensive patients are diagnosed and receiving treatment. Diabetes mellitus (DM) is a metabolic disorder characterized by glucose levels exceeding normal values or perglycemia (≥200 mg/dl). to evaluate the cost-effectiveness of antihypertensive and anti-diabetic in patients who are hospitalized at Efarina Etaham Berastagi Hospital, Karo. This research is non-experimental using data taken from patient medical records retrospectively for the period January-June 2017. The analytical method used is Cost Effectiveness Analysis (CEA). The Cost Effectiveness Average Ratio (CEA Ratio) and Incremental Cost Effectiveness Ratio (ICER) methods were used to analyze the most cost-effective antihypertensives and antidiabetics. The results of this study showed that the hypertension therapy regimens used were amlodipine, captropil, valsartan, amlodipine + captropil, amlodipine + valsartan, captorpil + valsartan, and amlodipine + captorpil + valsartan. In the anti-diabetic therapy regimen used are insulin analogues, metmorphine and insulin analogues + metmorphine. The most cost-effective antihypertensive based on the CEA and ICER is amdolpine + captropil and the most cost-effective diabetic liver based on the CEA and ICER is metmorphine. amlodipine + captropil, amlodipine + valsartan, captorpil + valsartan, and amlodipine + captorpil + valsartan. In the anti-diabetic therapy regimen used are insulin analogues, metmorphine and insulin analogues + metmorphine. The most cost-effective antihypertensive based on the CEA and ICER is amdolpine + captropil and the most cost-effective diabetic liver based on the CEA and ICER is metmorphine. amlodipine + captropil, amlodipine + valsartan, captorpil + valsartan, and amlodipine + captorpil + valsartan. In the anti-diabetic therapy regimen used are insulin analogues, metmorphine and insulin analogues + metmorphine. The most cost-effective antihypertensive based on the CEA and ICER is amdolpine + captropil and the most cost-effective diabetic liver based on the CEA and ICER is metmorphine.
References
Andayani, TM (2013). Pharmacoeconomics Principles And Methodology. Yogyakarta: Knowledge Exchange. Pages 3, 84-85.
American Diabetes Association (ADA) (2015). Position Statement: Standards of
Medical — Care in Diabetes 2015. Diabetes Care, vol. (Suppl. I).
http://care.diabetes j'ournals.org. Retrieved date: 26 March 2015. Page 59.
American Heart Association (AHA).(2003). Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation and Treatment
Of High Blood Pressure. http://hyper.ahajoumals.org. Accessed
date: March 26, 2017.Page 1286.
Indonesian Ministry of Health Balitbang (2013). Basic Health Researcher, RISKESDAS. Jakarta: Balitbang Ministry of Health RI.
Benowit, N.L (2010). Cardiovascular-Kidney Drugs. In: Pharmacology
Basic And Kimik Edition 10. Editor: Bertram G. Katzung Jakarta: EGC. Page 174.
Chobanian, A.V., George LB, Henry R. (2003). Seventh Repoth Of The Joint
National Committee On Prevention, Detection, Evaluation And
Treatment Of High Blood Pressure.USA, Department Of Health And
Human Services. http://hyper.ahajournals.org. Retrieved March 26, 2015. Page 1208.
Dipiro, JT, Robert LT, Gary C. Yee, Gary R. Matzke
(2008). Pharmacotherapy A Pathophysiologic Approach. Seventh Edition. America: McGraw Hill Medical. Pages 139, 1209.
Fauci, S A., Kasper LD, Longo LD, Braunwald E. (2008). Harrion's Principles of Internal Medicine. XVIL New York Edition: The McGraw Hills Company. Page 1403.
Nasir, Abd, Abdul M, Ideputri. (2011). Health Research Methodology. Yogyakarta. Nuha Medika. Pages 196, 199-200.
Rahajeng, E, and Tuminah, 8 (2009) Prevalence of Hypertension and Its Determinants in Indonesia Indonesian Medical Magazine. Volume 99 Number 12
page 583
Rascati, KL. (2009) Essential af Pharmacoeconomics. Philadelphia. Lippincott Williams and Wilkins. Page 82.
Suherman. SK (2007). Insulin and Oral Antidiabetics. In Book F'Armacology Therapeutic Edition V. Jakarta: FK Ul Page 485.
Downloads
Details
License
Copyright (c) 2020 Hendri Kurniawan, Ismi Noer Fadilah
This work is licensed under a Creative Commons Attribution 4.0 International License.
